Efficacy of docetaxel combined with pirarubicin in the treatment of advanced breast cancer
10.3969/j.issn.1005-1678.2017.08.039
- VernacularTitle:多西他赛联合吡柔比星在晚期乳腺癌的护理干效果分析
- Author:
Daoxia PAN
;
Huiwen YANG
- Keywords:
docetaxel;
pirarubicin;
breast cancer;
nursing intervention.
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(8):95-96,99
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the nursing intervention and efficacy of docetaxel combined with pirarubicin in the treatment of advanced breast cancer. Methods In our hospital from January 2014 to February 2015 were selected from the patients with advanced breast cancer in 94 cases as the research object, the single and double number (hospital admission order) of the selected patients with advanced breast cancer were randomly divided into study group and control group, 41 cases in each group. 2 groups of patients with advanced breast cancer were treated with docetaxel combined with pirarubicin, the control group was given routine nursing services, and the study group was given comprehensive nursing intervention measures on the basis of routine care. Results Of the 2 groups of patients with advanced breast cancer nursing after different nursing measures the same drug plan, after the study group, the total efficiency of treatment in the method [please explain what is near total efficiency] (82.98%) was significantly better than the control group (61.70%), the difference was statistically significant (P<0.05); the study group the nursing service satisfaction was significantly better than the control group (P<0.05). Conclusion With the combination of docetaxel and pirarubicin in the treatment of advanced breast cancer patients, comprehensive nursing measures can achieve better clinical efficacy and benefit the maintenance of good relationship between nurses and patients.
